Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA (MRK)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Merck KGaA : Effect Pigments for Architecture: Merck Exhibits at the Middle East Coatings Show 2012

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/05/2012 | 10:24am CET

Darmstadt/Germany, March 5, 2012 - Merck will be presenting its effect pigments for architecture at the Middle East Coatings Show in Dubai from March 12 to 14, 2012. This exhibition is the most important platform for the coatings sector in the Middle East and the Gulf region. The focus of the exhibition will be on architectural applications, which have been seeing rapid growth in the region for the past several years. The trend toward gold and silver shades, which can currently be seen in lifestyle products and interior designs, is also being reflected in architecture.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MERCK KGAA
01/19 MERCK KGAA : Darmstadt, Germany Presents Data on Bifunctional Immunotherapy M782..
01/19 MERCK : Study Data from Merck KGaA Update Knowledge of Melanoma (Psychometric pr..
01/19 MERCK : Frost & Sullivan Applauds Merck KGaA Darmstadt, Germany for Successfully..
01/16 Health-conscious Nestle sells U.S. candy to Ferrero for $2.8 billion
01/16 MERCK : Darmstadt, Germany Presents Data on Bifunctional Immunotherapy M7824 at ..
01/10 Nestle frontrunner for Merck KGaA's consumer health business - Bloomberg
01/08 MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German ..
2017 MERCK KGAA : - FDA Grants Breakthrough Therapy Designation for Avelumab in Combi..
2017 PFIZER : FDA Grants Breakthrough Therapy Designation for Avelumab in Combination..
2017 MERCK : Singapore’s IP Office to Grant MilliporeSigma’s Patent Appli..
More news
News from SeekingAlpha
01/10 Nestle frontrunner for Merck KGaA's consumer health unit
01/09 Merck (MKGAY) Presents At 36th Annual J.P. Morgan Healthcare Conference - Sli..
2017 WEEK IN REVIEW : 2017 Was Record Investment Year For China Life Science; Final W..
2017 Merck KGaA's Bavencio + Pfizer's Inlyta a Breakthrough Therapy for first-line..
2017 Britain's cost watchdog backs Novartis' MS med Extavia for use by NHS
Financials (€)
Sales 2017 15 340 M
EBIT 2017 3 417 M
Net income 2017 1 697 M
Debt 2017 9 777 M
Yield 2017 1,42%
P/E ratio 2017 19,83
P/E ratio 2018 20,28
EV / Sales 2017 1,39x
EV / Sales 2018 1,25x
Capitalization 11 588 M
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 108 €
Spread / Average Target 20%
EPS Revisions
Managers
NameTitle
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Crocifissa Attardo Member-Supervisory Board
Mechthild Auge Member-Supervisory Board
Michael Fletterich Vice Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA0.41%14 160
ABBVIE7.91%166 806
KYOWA HAKKO KIRIN CO LTD-2.84%11 243
JAZZ PHARMACEUTICALS PLC10.84%8 915
ZHANGZHOU PIENTZEHUANG PHARMACEUTICL LTD16.69%6 876
CONVATEC GROUP-7.30%5 070